Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04895592Phase 1Completed
Phase 1, randomised, open-label trial of dexamethasone in brain metastases (2 arms), sponsored by Emory University. Primary endpoint: Incidence of adverse events grade 3 or greater at 4 months. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04895592.